1. Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-1-Infektion [Internet]. 2014 [cited 15.09.2014]. Available from: http://www.daignet.de/site-content/hiv-therapie/leitlinien-1/Deutsch_Osterreichische%20Leitlinien%20zur%20antiretroviralen%20Therapie%20der%20HIV_Infektion%2006_2014.pdf
2. Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort;Stoll;PloS one.,2011
3. Robert Koch Institut. Epidemiologisches Bulletin 47/2008 [Internet]. 2008 [cited 2014]. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2008/Ausgaben/47_08.pdf?__blob=publicationFile
4. Bartmeyer B, Kollan C, Stoll M, Bogner J, Fätkenheuer G, Stellbrink H, et al. Estimation of total number of persons infected with HIV initiating and receiving antiretroviral therapy (ART) in Germany (2006-2008) from national antiretroviral prescription data (APD) [Internet]. 2010 [cited 06.02.2012]. Available from: http://www.rki.de/DE/Content/InfAZ/H/HIVAIDS/Epidemiologie/Surveillance/ClinSurv/ClinSurv-IAC-2010-Abstract.pdf?__blob=publicationFile
5. Robert-Koch-Institut. Anlage zum Epidemiologischen Bulletin Nr. 46 [Internet]. 2011 Available from: http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2011/Ausgaben/46_11_Anlage.pdf?__blob=publicationFile